Additionally, CDKN2B-function AS1’s and mechanisms in human breast cancer were studied by Qin et al. They demonstrated that CDKN2B-AS1 regulated serine/threonine kinase 39 (STK39) expression by acting as a miR-122-5p sponge, aiding breast cancer advancement. Here, STK39 is linked to breast carcinoma.